CONNECTED MEDICAL DEVICE MARKET ANALYSIS

Key Developments

• In October 2023, ZS launched ZAIDYN Connected Health, an AI-driven solution within the ZAIDYN by ZS platform. This tool assists pharmaceutical companies, healthcare providers, and payers in addressing unmet needs, enhancing patient engagement, and improving health outcomes by providing reliable intelligence in a dynamic healthcare environment.
• In August 2022, Medtronic plc announced a strategic partnership with BioIntelliSense, focusing on the exclusive rights for the BioButton multi-parameter wearable device for usage in U.S. hospitals and for 30-day post-acute hospital-to-home distribution. This partnership enables Medtronic's Patient Monitoring business to utilize a medical-grade device that provides continuous vital sign measurements for general care patients both in-hospital and after discharge.
• In March 2022, Microsoft Corp. introduced updates to Microsoft Cloud for Healthcare and advancements in cloud technologies for life sciences and healthcare, including the general availability of Azure Health Data Services. Following its acquisition of Nuance Communications, Microsoft aims to enhance organizations' abilities to leverage trusted AI in addressing major healthcare challenges and shaping the future of the industry.
• In January 2022, Abbott launched Lingo, a new consumer bio wearable designed to monitor critical body signals such as ketones, glucose, and lactate. This device aims to help individuals better understand their overall health and take appropriate actions based on the data.